Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus
暂无分享,去创建一个
F. Nieto | F. Brancati | E. Shahar | M. Wofford | F L Brancati | F J Nieto | E Shahar | T. Gress | T W Gress | M R Wofford | F. Nieto
[1] J. Pena,et al. The preservation of cadaveric kidneys for transplantation. , 1970, The British journal of surgery.
[2] P Whelton,et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. , 1995, Hypertension.
[3] T. Asano,et al. Insulin resistance with enhanced insulin signaling in high-salt diet-fed rats. , 2001, Diabetes.
[4] L. Goodman,et al. The Pharmacological Basis of Therapeutics , 1976 .
[5] H. Lithell,et al. Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala. , 1991, BMJ.
[6] R. J. Hawley. Frequency of median mononeuropathy in patients with mild diabetic neuropathy in the early diabetes intervention trial (EDIT) , 1996, Muscle & nerve.
[7] E. Frohlich,et al. Diabetes, Hypertension, and Cardiovascular Disease: An Update , 2001, Hypertension.
[8] I. Holme,et al. Serum glucose levels during long-term observation of treated and untreated men with mild hypertension. The Oslo study. , 1984, The American journal of medicine.
[9] L. Geiss,et al. Prevalence and Incidence of Non-Insulin-Dependent Diabetes , 1996 .
[10] Aric Invest. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators , 1989 .
[11] L. Ruilope,et al. Blood Pressure Control and Benefits of Antihypertensive Therapy: Does It Make a Difference Which Agents We Use? , 2001, Hypertension.
[12] L. Wilkins. Propranolol or hydrochlorothiazide alone for the initial treatment of hypertension. IV. Effect on plasma glucose and glucose tolerance. Veterans Administration Cooperative Study Group on Antihypertensive Agents. , 1985, Hypertension.
[13] W. Parmley,et al. Drug-Induced Diabetes: Diabetogenic Activity of Long-Term Administration of Benzothiadiazines , 1963 .
[14] B. Jönsson,et al. The economic impact of diabetes. , 1998, Diabetes care.
[15] D. Grobbee,et al. Cardiovascular drug use and hospitalizations attributable to type 2 diabetes. , 2001, Diabetes care.
[16] T. Egeland,et al. Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[17] G. Bakris,et al. Antihypertensive therapy and the risk of type 2 diabetes mellitus. , 2000, The New England journal of medicine.
[18] T. Pischon,et al. Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis. , 2001, Hypertension.
[19] C. Dollery,et al. Effect of diuretic therapy on glucose tolerance in hypertensive patients. , 1971, Lancet.
[20] T. Hedner,et al. Diabetes mellitus in treated hypertension: incidence, predictive factors and the impact of non-selective beta-blockers and thiazide diuretics during 15 years treatment of middle-aged hypertensive men in the Primary Prevention Trial Göteborg, Sweden. , 1994, Journal of human hypertension.
[21] B. Davis,et al. Influence of Long-term, Low-Dose, Diuretic-Based, Antihypertensive Therapy on Glucose, Lipid, Uric Acid, and Potassium Levels in Older Men and Women With Isolated Systolic Hypertension The Systolic Hypertension in the Elderly Program , 1998 .
[22] J. Cutler,et al. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. , 1993, JAMA.
[23] B. Psaty,et al. Health Outcomes Associated with Antihypertensive Therapies Used as First-Line Agents: A Systematic Review and Meta-analysis , 1998 .
[24] F. Messerli,et al. Diabetes, hypertension, and cardiovascular disease: an update. , 2001, Hypertension.
[25] A. Folsom,et al. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.
[26] S. Haffner,et al. Incidence of NIDDM and Impaired Glucose Tolerance in Hypertensive Subjects: The San Antonio Heart Study , 1993, Diabetes.
[27] C. Dollery,et al. Glucose Tolerance During Antihypertensive Therapy in Patients with Diabetes Mellitus , 1985, Hypertension.
[28] A. Hartmann,et al. Hypertension after kidney transplantation: are treatment guidelines emerging? , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[29] C. Bengtsson,et al. Do antihypertensive drugs precipitate diabetes? , 1984, British medical journal.
[30] S. Jacob,et al. Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta-blocking agents? , 1998, American journal of hypertension.
[31] C. Lewis,et al. Treatment of Mild Hypertension Study: Final Results , 1993 .
[32] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[33] Samy I McFarlane,et al. Insulin resistance and cardiovascular disease. , 2001, The Journal of clinical endocrinology and metabolism.
[34] A. Fletcher,et al. Adverse treatment effects in the trial of the European Working Party on High Blood Pressure in the Elderly. , 1991, The American journal of medicine.
[35] Charles R. Hart,et al. At Chapel Hill , 1947 .
[36] T. Welborn,et al. Glucose tolerance in hypertensive patients on long-term diuretic therapy. , 1967, Lancet.
[37] P. Grambsch,et al. Proportional hazards tests and diagnostics based on weighted residuals , 1994 .
[38] H. Lithell,et al. Do antihypertensive drugs precipitate diabetes in predisposed men? , 1989, BMJ.
[39] J. Ziegenhorn,et al. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. , 1983, Clinical chemistry.
[40] A. Helgeland. Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. , 1980, The American journal of medicine.
[41] T. Asano,et al. High-Salt Diet Enhances Insulin Signaling and Induces Insulin Resistance in Dahl Salt-Sensitive Rats , 2002, Hypertension.
[42] C. Dollery,et al. GLUCOSE INTOLERANCE IN HYPERTENSIVE PATIENTS TREATED WITH DIURETICS; A FOURTEEN-YEAR FOLLOW-UP , 1982, The Lancet.
[43] A. Hartmann,et al. Insulin resistance after renal transplantation: impact of immunosuppressive and antihypertensive therapy. , 2001, Diabetes care.
[44] R. Holman,et al. The Fasting Hyperglycaemia Study: I. Subject identification and recruitment for a non-insulin-dependent diabetes prevention trial. , 1997, Metabolism: clinical and experimental.
[45] S. Haffner,et al. Do interventions to reduce coronary heart disease reduce the incidence of type 2 diabetes? A possible role for inflammatory factors. , 2001, Circulation.
[46] G. Sartor,et al. Ten-year Follow-up of Subjects with Impaired Glucose Tolerance: Prevention of Diabetes by Tolbutamide and Diet Regulation , 1980, Diabetes.
[47] M. Laakso,et al. Increased risk of non‐insulin-dependent diabetes mellitus in elderly hypertensive subjects , 1994, Journal of hypertension.
[48] A. P. Shapiro,et al. Effect of Thiazides on Carbohydrate Metabolism in Patients with Hypertension , 1961 .
[49] O. Andersson,et al. Low-dose antihypertensive treatment with a thiazide diuretic is not diabetogenic. A 10-year controlled trial with bendroflumethiazide. , 2009, Acta medica Scandinavica.
[50] J. Manson,et al. Risk Factors for Non‐Insulin‐Dependent Diabetes Mellitus Requiring Treatment in the Elderly , 1994, Journal of The American Geriatrics Society.
[51] Bell Ds. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. , 2000 .
[52] H. Blackburn,et al. Cardiovascular survey methods. , 1969, East African medical journal.
[53] R. Wenk,et al. Simple, rapid, kinetic method for serum creatinine measurement. , 1972, Clinical chemistry.
[54] J E Frijters,et al. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. , 1982, The American journal of clinical nutrition.
[55] H. Aburatani,et al. Angiotensin II–Induced Insulin Resistance Is Associated With Enhanced Insulin Signaling , 2002, Hypertension.
[56] Melvin Prince,et al. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. , 1999, Diabetes care.
[57] P. Weidmann,et al. Requirements for antihypertensive therapy in diabetic patients: metabolic aspects , 1997, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[58] J. Gurwitz,et al. Antihypertensive Drug Therapy and the Initiation of Treatment for Diabetes Mellitus , 1993 .